Dataset from A Prospective, Randomized, Open-label Comparison of a Long-Acting Basal Insulin Analog LY2963016 to Lantus in Combination With Mealtime Insulin Lispro in Adult Patients With Type 1 Diabetes Mellitus

The purpose of this study is to compare the effectiveness and safety of LY2963016 versus Lantus when taken once daily in combination with insulin lispro before meals three times a day.

本研究旨在比较LY2963016与甘精胰岛素（Lantus）每日一次给药，联合三餐前三次给予赖脯胰岛素（insulin lispro）时的有效性与安全性。